Organizing Committee:

Jeff Zablocki, Ph.D. (USA)
Patrick M. Woster, Ph.D. (USA)
Koen Augustyns, Ph.D. (Belgium)
Anders Karlen (Sweden)
Ulrich Stilz (Germany)

Scientific Advisory Committee:

Koen Augustyns (Belgium)
Peter Bernstein (USA)
Robert DeVita (USA)
Richard A. Gibbs (USA)
Anders Karlen (Sweden)
John Macor (USA)
Thomas Prisinzano (USA)
Patrick M. Woster (USA)
Ulrich Stilz (Germany)
Wendy Young (USA)
Jeff Zablocki (USA)

CLICK HERE to download a PDF copy of the Abstract Booklet

Dear Colleagues:
On behalf of the organizing and scientific committees, we would like to invite you to participate in the Frontiers in Medicinal Chemistry Symposium, to be held in San Francisco, CA, USA from Sunday, June 23 to Wednesday, 26, 2013. This symposium is the fourth in the series initiated in Siena, Italy in 2007 and continued in Barcelona, Spain in 2009 and Stockholm, Sweden in 2011. The theme of this year’s meeting is Emerging Targets, Novel Candidates and Innovative Strategies. The meeting is co-organized by the European Federation of Medicinal Chemistry and the American Chemical Society Division of Medicinal Chemistry. It is intended to bring scientists working in the medicinal chemistry field together in order to share new and exciting results and we encourage attendees to bring poster presentations. San Francisco provides a picturesque backdrop for this exciting conference, and we know you will have a scientifically rewarding and enjoyable stay.

Frontiers 2013 will take place in the historic Fairmont Hotel, located at 950 Mason St. on Nob Hill, in the heart of San Francisco. Central to the Financial District, Union Square, the Embarcadero and Fisherman's Wharf, the Fairmont Hotel is located at the only spot in San Francisco where each of the City's cable car lines meet.
The scientific program for Frontiers 2013 will feature a plenary session, followed by sessions covering the latest advances in medicinal chemistry. Session topic areas include:

Antiviral Drug Design
Advances in the Treatment of Inflammation
Imaging, Biomarkers & Translational Research
Antibody/Drug Conjugates
Molecular Modeling and Structure-Based Design
Emerging Topics